Literature DB >> 29381665

What's in a name: are menopausal "hot flashes" a symptom of menopause or a manifestation of neurovascular dysregulation?

Virginia M Miller1,2, Juliana M Kling3, Julia A Files3, Michael J Joyner4, Ekta Kapoor5,6, Ann M Moyer7, Walter A Rocca2,8,9, Stephanie S Faubion5.   

Abstract

Hot flashes have typically been classified as "symptoms of menopause" that should be tolerated or treated until they resolve. However, mounting evidence points to hot flashes as a manifestation of one or several underlying pathophysiological processes. Associations exist between the presence, timing of onset, severity, and duration of hot flashes, and the risk of several neurological (affecting sleep, mood, and cognition) and cardiovascular conditions. In addition, four consistent patterns of vasomotor disturbances have been identified across different countries, making it unlikely that these patterns are solely explained by socioeconomic or cultural factors. The changing hormonal environment of menopause may unmask differences in the autonomic neurovascular control mechanisms that put an individual woman at risk for chronic conditions of aging. These differences may have a genetic basis or may be acquired across the life span and are consistent with the variability of the clinical manifestations of aging observed in women after bilateral oophorectomy. It is time to investigate the pathophysiological mechanisms underlying the four patterns of vasomotor symptoms more closely, and to shift from describing hot flashes as symptoms to be tolerated to manifestations of an underlying autonomic neurovascular dysregulation that need to be addressed.

Entities:  

Mesh:

Year:  2018        PMID: 29381665      PMCID: PMC5970009          DOI: 10.1097/GME.0000000000001065

Source DB:  PubMed          Journal:  Menopause        ISSN: 1072-3714            Impact factor:   2.953


  46 in total

1.  Vasomotor symptom prevalence is associated with polymorphisms in sex steroid-metabolizing enzymes and receptors.

Authors:  Carolyn J Crandall; Sybil L Crawford; Ellen B Gold
Journal:  Am J Med       Date:  2006-09       Impact factor: 4.965

2.  Vascular function and cardiovascular risk factors in women with severe flushing.

Authors:  J Sassarini; H Fox; W Ferrell; N Sattar; M A Lumsden
Journal:  Clin Endocrinol (Oxf)       Date:  2011-01       Impact factor: 3.478

3.  Could personalized management of menopause based on genomics become a reality?

Authors:  Ann M Moyer; Virginia M Miller; Stephanie S Faubion
Journal:  Pharmacogenomics       Date:  2016-05-04       Impact factor: 2.533

Review 4.  Modeling menopause: The utility of rodents in translational behavioral endocrinology research.

Authors:  Stephanie V Koebele; Heather A Bimonte-Nelson
Journal:  Maturitas       Date:  2016-02-03       Impact factor: 4.342

5.  Gender-selective interaction between aging, blood pressure, and sympathetic nerve activity.

Authors:  Krzysztof Narkiewicz; Bradley G Phillips; Masahiko Kato; Dagmara Hering; Leszek Bieniaszewski; Virend K Somers
Journal:  Hypertension       Date:  2005-03-14       Impact factor: 10.190

6.  Vasomotor symptoms and cardiovascular events in postmenopausal women.

Authors:  Emily D Szmuilowicz; JoAnn E Manson; Jacques E Rossouw; Barbara V Howard; Karen L Margolis; Nancy C Greep; Robert G Brzyski; Marcia L Stefanick; Mary Jo O'Sullivan; Chunyuan Wu; Matthew Allison; Diederick E Grobbee; Karen C Johnson; Judith K Ockene; Beatriz L Rodriguez; Gloria E Sarto; Mara Z Vitolins; Ellen W Seely
Journal:  Menopause       Date:  2011-06       Impact factor: 2.953

Review 7.  Menopausal hot flushes and night sweats: where are we now?

Authors:  D F Archer; D W Sturdee; R Baber; T J de Villiers; A Pines; R R Freedman; A Gompel; M Hickey; M S Hunter; R A Lobo; M A Lumsden; A H MacLennan; P Maki; S Palacios; D Shah; P Villaseca; M Warren
Journal:  Climacteric       Date:  2011-08-18       Impact factor: 3.005

8.  Evidence for a role of hot flushes in vascular function in recently postmenopausal women.

Authors:  Pauliina Tuomikoski; Pia Ebert; Per-Henrik Groop; Petri Haapalahti; Hanna Hautamäki; Mats Rönnback; Olavi Ylikorkala; Tomi S Mikkola
Journal:  Obstet Gynecol       Date:  2009-04       Impact factor: 7.661

9.  Impact of CYP19A1 and ESR1 variants on early-onset side effects during combined endocrine therapy in the TEXT trial.

Authors:  Harriet Johansson; Kathryn P Gray; Olivia Pagani; Meredith M Regan; Giuseppe Viale; Valentina Aristarco; Debora Macis; Antonella Puccio; Susanne Roux; Rudolf Maibach; Marco Colleoni; Manuela Rabaglio; Karen N Price; Alan S Coates; Richard D Gelber; Aron Goldhirsch; Roswitha Kammler; Bernardo Bonanni; Barbara A Walley
Journal:  Breast Cancer Res       Date:  2016-11-08       Impact factor: 6.466

10.  Neurokinin 3 receptor antagonism as a novel treatment for menopausal hot flushes: a phase 2, randomised, double-blind, placebo-controlled trial.

Authors:  Julia K Prague; Rachel E Roberts; Alexander N Comninos; Sophie Clarke; Channa N Jayasena; Zachary Nash; Chedie Doyle; Deborah A Papadopoulou; Stephen R Bloom; Pharis Mohideen; Nicholas Panay; Myra S Hunter; Johannes D Veldhuis; Lorraine C Webber; Les Huson; Waljit S Dhillo
Journal:  Lancet       Date:  2017-04-03       Impact factor: 79.321

View more
  5 in total

1.  Sympathetic neural responsiveness to sleep deprivation in older adults: sex differences.

Authors:  Jason R Carter; Ida T Fonkoue; Ian M Greenlund; Christopher E Schwartz; Babak Mokhlesi; Carl A Smoot
Journal:  Am J Physiol Heart Circ Physiol       Date:  2019-05-31       Impact factor: 4.733

2.  A qualitative assessment of health behaviors and experiences during menopause: A cross-sectional, observational study.

Authors:  Kara L Marlatt; Robbie A Beyl; Leanne M Redman
Journal:  Maturitas       Date:  2018-07-21       Impact factor: 4.342

3.  Complementary and alternative treatment methods for menopausal hot flashes used in Turkey.

Authors:  Handan Ozcan; Pınar Çolak; Berna Oturgan; Esra Gülsever
Journal:  Afr Health Sci       Date:  2019-12       Impact factor: 0.927

4.  Life-Course Reproductive History and Cardiovascular Risk Profile in Late Mid-Life: The CARDIA Study.

Authors:  Abbi D Lane-Cordova; Erica P Gunderson; Philip Greenland; Janet M Catov; Cora E Lewis; Kelley Pettee Gabriel; Melissa F Wellons; Mercedes R Carnethon
Journal:  J Am Heart Assoc       Date:  2020-05-05       Impact factor: 5.501

5.  Hypertensive disorders of pregnancy and menopausal symptoms: a cross-sectional study from the data registry on experiences of aging, menopause, and sexuality.

Authors:  Stephanie S Faubion; Amanda King; Andrea G Kattah; Carol L Kuhle; Richa Sood; Juliana M Kling; Kristin C Mara; Ekta Kapoor
Journal:  Menopause       Date:  2020-08-17       Impact factor: 3.310

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.